Skip to main content
Clinical Trials/NL-OMON32524
NL-OMON32524
Completed
N/A

Cognitive dysfunction and developmental risks for severe psychopathology: insights from sex chromosomal disorders - Neurodevelopmental risks in sex chromosomal disorders

niversiteit Leiden0 sites200 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
sex chromosomal aneuploidy
Sponsor
niversiteit Leiden
Enrollment
200
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversiteit Leiden

Eligibility Criteria

Inclusion Criteria

  • General inclusion criteria include age between 4 and 12 (for the fMRI study: age between 9 and 12\), voluntary participation, Dutch speaking and signed informed consent from parents. The specific inclusion criteria for the four groups are as following:;Klinefelter syndrome: diagnosed with (non\-mosaic) Klinefelter syndrome based on the presence of a 47,XXY chromosomal pattern as determined by karyotyping.
  • Turner syndrome: diagnosed with (non\-mosaic) Turner syndrome based on the presence of a 46,XO chromosomal pattern as determined by karyotyping.
  • Autism spectrum condition: an autism spectrum diagnosis according to DSM\-IV or ICD\-10 criteria
  • Non\-clinical controls: n/a

Exclusion Criteria

  • Clinical groups:
  • \- history of closed\-head injury or neurological illness
  • \- contraindications for MRI (part 2 study)
  • \- premature birth;Non\-clinical groups:
  • \- use of psychotropic medication
  • \- history of psychiatric illness, closed\-head injury, neurological illness or endocrinological dysfunction
  • \- contraindications for fMRI
  • \- premature birth

Outcomes

Primary Outcomes

Not specified

Similar Trials